PT2411503T - Salmonella enterica que apresenta n-glicano de c. jejuni ou derivados do mesmo - Google Patents

Salmonella enterica que apresenta n-glicano de c. jejuni ou derivados do mesmo

Info

Publication number
PT2411503T
PT2411503T PT107150989T PT10715098T PT2411503T PT 2411503 T PT2411503 T PT 2411503T PT 107150989 T PT107150989 T PT 107150989T PT 10715098 T PT10715098 T PT 10715098T PT 2411503 T PT2411503 T PT 2411503T
Authority
PT
Portugal
Prior art keywords
jejuni
glycan
presenting
derivatives
salmonella enterica
Prior art date
Application number
PT107150989T
Other languages
English (en)
Inventor
Ilg Karin
Aebi Markus
Ahuja Umesh
Amber Saba
Schwarz Flavio
Original Assignee
Eidgenössische Technische Hochschule Zürich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eidgenössische Technische Hochschule Zürich filed Critical Eidgenössische Technische Hochschule Zürich
Publication of PT2411503T publication Critical patent/PT2411503T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT107150989T 2009-03-27 2010-03-25 Salmonella enterica que apresenta n-glicano de c. jejuni ou derivados do mesmo PT2411503T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09004445 2009-03-27

Publications (1)

Publication Number Publication Date
PT2411503T true PT2411503T (pt) 2017-11-15

Family

ID=42199060

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107150989T PT2411503T (pt) 2009-03-27 2010-03-25 Salmonella enterica que apresenta n-glicano de c. jejuni ou derivados do mesmo

Country Status (14)

Country Link
US (2) US9309493B2 (pt)
EP (1) EP2411503B1 (pt)
JP (1) JP5568626B2 (pt)
KR (1) KR101395431B1 (pt)
CN (1) CN102365359B (pt)
BR (1) BRPI1010283B8 (pt)
CA (1) CA2757224C (pt)
ES (1) ES2646320T3 (pt)
IL (1) IL215239A (pt)
MX (1) MX2011009791A (pt)
PL (1) PL2411503T3 (pt)
PT (1) PT2411503T (pt)
RU (1) RU2507253C2 (pt)
WO (1) WO2010108682A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102724997B (zh) * 2009-11-19 2016-09-21 格林考瓦因有限公司 在原核细胞中产生免疫原性多糖的生物合成***
AU2012306345A1 (en) * 2011-09-06 2014-03-20 Glycovaxyn Ag Bioconjugate vaccines made in prokaryotic cells
WO2013159234A1 (en) 2012-04-27 2013-10-31 The Governors Of The University Of Alberta Glycoengineered outer membrane vesicles and use thereof as vaccines
EP2991675B1 (en) 2013-04-05 2019-07-24 The Governors of the University of Alberta Campylobacter vaccine
CN103740632B (zh) * 2014-01-22 2016-02-10 山东大学 一株重组大肠杆菌及其在制备抗o157:h7的n-糖蛋白疫苗中的应用
MA47383A (fr) 2017-01-27 2019-12-04 Univ Florida Vaccin de sécurité alimentaire pour lutter contre salmonella enterica et réduire campylobacter chez la volaille
US11179454B2 (en) 2017-03-15 2021-11-23 London School Of Hygiene And Tropical Medicine Whole cell vaccines
PE20171768A1 (es) * 2017-06-12 2017-12-21 Farm Veterinarios S A C Obtencion de una salmonela enteritidis tipo rugosa y sus modificaciones geneticas para uso como vacuna aviar
BR112020012553A2 (pt) * 2017-12-19 2020-11-24 The Governors Of The University Of Alberta glicanos de superfície de clostridium perfringens e usos dos mesmos
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399074B1 (en) * 1998-07-24 2002-06-04 Megan Health, Inc. Live attenuated salmonella vaccines to control avian pathogens
EE05691B1 (et) * 2001-05-03 2013-12-16 Fit Biotech Oyj Plc Ekspressioonivektorid ja nende rakendused
CA2494223C (en) * 2002-08-01 2012-10-02 National Research Council Of Canada Campylobacter glycans and glycopeptides
RU2237089C2 (ru) * 2002-10-31 2004-09-27 Государственный научный центр вирусологии и биотехнологии "Вектор" Рекомбинантный аттенуированный штамм бактерий salmonella enteriditis е-23/pgex-2t-tbi как кандидат для конструирования живой вакцины против вируса иммунодефицита человека
CN1791433B (zh) * 2003-03-24 2010-05-26 斯克里普斯研究学院 抗肿瘤生长的dna疫苗及其使用方法
RU2248396C2 (ru) * 2003-04-17 2005-03-20 Государственный научный центр вирусологии и биотехнологии "Вектор" Рекомбинантная плазмидная днк pcdna-tci, обеспечивающая экспрессию искусственного гена tci в клетках эукариот, и рекомбинантный аттенуированный штамм бактерий salmonella enteritidis e-23/pcdna-tci как кандидат для конструирования живой днк-вакцины против вируса иммунодефицита человека
EP1655370A1 (en) * 2004-11-05 2006-05-10 Gesellschaft für Biotechnologische Forschung Bacterial vector
SI2311972T1 (sl) * 2005-05-11 2015-08-31 Eth Zuerich Rekombinantni N-glikozilirani proteini iz prokariontskih celic
JP5044754B2 (ja) 2005-09-21 2012-10-10 アメリカ合衆国 カンピロバクター・ジェジュニに対するワクチン成分として使用される免疫原莢膜組成物
DE102008012452A1 (de) * 2008-03-04 2009-09-10 Tridonicatco Gmbh & Co. Kg Schaltung zum Beheizen und Überwachen der Heizwendeln mindestens einer mit einem elektronischen Vorschaltgerät betriebenen Gasentladungslampe auf Wendelbruch

Also Published As

Publication number Publication date
BRPI1010283B8 (pt) 2021-05-25
US20160213770A1 (en) 2016-07-28
WO2010108682A1 (en) 2010-09-30
RU2011143381A (ru) 2013-05-10
MX2011009791A (es) 2011-10-17
BRPI1010283B1 (pt) 2021-04-06
KR101395431B1 (ko) 2014-05-14
US9764021B2 (en) 2017-09-19
JP2012521747A (ja) 2012-09-20
KR20110127714A (ko) 2011-11-25
IL215239A (en) 2016-02-29
RU2507253C2 (ru) 2014-02-20
IL215239A0 (en) 2011-12-29
CN102365359A (zh) 2012-02-29
CN102365359B (zh) 2014-10-29
CA2757224C (en) 2016-12-06
PL2411503T3 (pl) 2018-01-31
ES2646320T3 (es) 2017-12-13
EP2411503A1 (en) 2012-02-01
CA2757224A1 (en) 2010-09-30
US20120100177A1 (en) 2012-04-26
JP5568626B2 (ja) 2014-08-06
US9309493B2 (en) 2016-04-12
BRPI1010283A2 (pt) 2016-10-11
EP2411503B1 (en) 2017-09-13

Similar Documents

Publication Publication Date Title
IL215239A0 (en) Salmonella enterica presenting c.jejuni n-glycan or derivatives thereof
AP2012006216A0 (en) Benzimidazole-imidazole derivatives.
ZA201205788B (en) 1,2,4-triazine-4-amine derivatives
IL219694A0 (en) Sweetener and method for the production thereof
AP2011005821A0 (en) Processing biomas.
BRPI0906394A2 (pt) Maca
ZA200904060B (en) Salmonella vaccine
GB2520450B (en) Over-speed detection system
EP2464363A4 (en) NATURAL EXTRACT FROM WHOLE BANANAS (MUSA SPP.)
EP2446755A4 (en) STERILIZER FOR FOOD
DK2639234T3 (da) Krystallinsk 6,7-umættet 7-carbamoylmorphinanderivat og fremgangsmåde til fremstilling heraf
ZA200906132B (en) Improved disinfestation method
PL2400862T3 (pl) Sposób utrwalania artykułów spożywczych
GB0910464D0 (en) Indicator, application thereof and related products
AP2012006340A0 (en) Turbine.
SI2513119T1 (sl) 3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati
EP2402744A4 (en) AUFKOHLUNGSERKENNUNGSVERFAHREN
MY165626A (en) 1,2,4,-triazolone derivative
EP2263475A4 (en) FOODS WITH LOW PROTEIN COMPONENT AND MANUFACTURING METHOD THEREFOR
EP2284283A4 (en) METHODS AND REAGENTS FOR DETECTION OF SALMONELLA SP.
EP2387417A4 (en) BROAD SPECTRUM VACCINE AGAINST NON-TYPHOID SALMONELLA
GB201117793D0 (en) Locking penetrator
AP2011005885A0 (en) Flavanoid compounds and process for preparation thereof.
EP2457921A4 (en) AUREOLIC ACID DERIVATIVES, PROCESS FOR OBTAINING THEM AND USES THEREOF
GB2448147B (en) Food processing